Nuvasive inc (NUVA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Operating activities:
Consolidated net income

61,146

65,234

47,515

52,428

48,997

12,479

23,363

40,536

40,740

79,855

62,825

33,224

51,279

35,471

40,563

49,818

30,068

65,290

61,480

46,743

32,434

-17,496

-18,952

-9,685

-12,144

6,985

-1,628

-6,769

2,569

2,442

-5,128

-74,942

-72,530

-71,021

858

76,637

77,805

76,533

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

136,511

135,593

134,601

133,228

131,729

129,765

128,663

126,639

123,756

121,176

117,870

115,072

110,999

102,713

90,674

79,614

71,088

65,915

68,322

67,424

66,525

65,837

63,338

63,808

63,888

63,106

59,961

56,937

54,403

51,909

49,632

45,667

40,548

36,242

0

0

0

-

-

-

0

Amortization of non-cash interest

23,221

21,288

20,990

20,697

20,408

20,123

19,848

19,576

20,094

20,538

21,491

22,660

22,978

22,721

21,502

20,045

18,632

17,851

17,501

17,158

16,821

16,490

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of strategic investment

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on repurchases of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-19,085

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

21,722

30,297

24,058

27,297

27,256

25,673

29,469

17,974

19,508

22,391

22,263

29,978

29,449

26,924

25,278

25,067

23,084

26,203

29,478

30,631

33,534

33,687

34,017

34,241

34,217

33,240

29,914

26,894

26,478

26,312

28,681

31,365

30,745

32,070

30,710

29,913

29,737

28,225

0

0

0

Reserves on current assets

19,829

18,382

15,257

13,657

14,539

14,834

14,993

15,002

11,700

5,622

4,170

4,765

5,292

11,452

11,249

12,122

12,983

9,454

5,026

3,556

1,123

1,856

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss on strategic investments

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Valuation Allowances and Reserves, Period Increase (Decrease)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Allowance for doubtful accounts and sales return reserves

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

900

2,438

2,002

1,345

1,305

541

-332

-995

0

0

0

Allowance for excess and obsolete inventory, net of write-offs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,386

4,962

7,012

6,028

4,567

3,042

1,087

1,607

0

0

0

Accretion of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Other non-cash adjustments

-7,881

-5,650

-14,359

-14,382

-20,902

-22,186

-20,797

-20,019

-16,709

-15,266

-16,588

-15,921

-16,450

-16,928

-15,823

-15,299

-14,900

-17,581

-15,001

-19,746

-17,702

-13,191

-14,552

-7,055

-7,367

-7,116

-6,162

-7,917

-7,247

-7,283

-14,774

-7,730

-6,251

-6,227

-2,903

-3,291

-6,720

-3,844

0

0

0

Amortization of Financing Costs and Discounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

614

1,972

1,894

1,816

0

0

0

-

-

-

-

Deferred income taxes

13,402

5,844

8,352

918

2,822

-11,396

-18,499

-16,354

-26,949

-12,838

-2,795

8,524

30,362

26,292

22,520

29,452

21,112

34,757

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable

-4,382

16,407

12,705

7,892

10,751

-4,562

5,540

9,935

11,396

26,610

42,831

40,629

38,641

33,421

14,664

18,715

8,455

9,463

10,783

9,225

11,340

18,465

14,650

17,544

16,959

17,384

18,679

11,119

5,817

2,005

4,660

3,907

8,678

9,929

3,248

14,702

13,823

17,865

0

0

0

Inventory

56,715

54,872

50,726

50,887

45,812

38,646

32,697

26,065

34,193

35,867

36,862

40,022

26,975

22,624

28,639

53,184

46,800

25,984

13,921

-14,768

-1,767

21,343

31,443

28,252

28,647

21,002

13,549

13,735

11,618

11,022

51,325

15,991

14,014

17,170

-11,312

26,552

24,085

18,664

0

0

0

Prepaid expenses and other current assets

5,265

4,622

2,732

1,950

942

1,280

13,897

12,279

11,804

12,681

249

7,146

7,792

3,875

4,730

-785

-2,098

-1,239

834

1,162

1,932

5,183

2,607

4,725

5,486

3,608

3,695

1,182

-837

-12,725

1,875

1,420

2,686

14,396

-2,834

1,499

1,286

2,105

0

0

0

Accounts payable and accrued liabilities

-6,275

-3,253

8,013

22,405

18,207

22,035

23,111

-200

-3,234

-4,263

548

2,860

2,905

12,376

4,768

15,285

335

7,742

3,198

-303

5,332

5,855

-1,765

8,834

12,243

4,665

11,373

2,866

5,477

2,938

5,591

7,817

490

-3,385

5,784

5,168

10,775

11,596

0

0

0

Accrued royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-46,092

-47,039

-41,894

-38,340

12,410

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued payroll and related expenses

-6,856

24,256

16,269

5,254

6,273

2,595

-5,836

-324

-1,797

3,975

10,756

11,138

5,339

8,841

3,218

3,822

752

-192

1,948

3,282

4,084

7,179

5,195

4,632

2,975

3,220

3,573

1,216

2,471

5,128

1,832

2,709

1,189

2,685

4,680

1,700

1,965

-1,877

0

0

0

Litigation liability

-

-

-

-

-

1,165

0

0

0

-

-

-

-

-

-

-

-

-36,270

24,667

64,795

67,730

30,000

-30,000

-22,500

-22,500

7,500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes

-2,450

3,804

-642

979

-1,501

2,054

4,758

-6,770

6,047

3,455

29,235

44,358

30,681

23,652

-20,213

-9,896

17,246

39,304

56,584

49,724

26,429

-4,053

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

216,040

235,290

229,279

235,396

207,283

219,183

208,629

187,123

185,174

176,969

180,894

124,936

128,863

158,085

136,739

153,757

120,096

88,727

67,072

102,420

118,271

115,548

123,790

113,366

96,633

97,439

100,729

96,707

114,448

130,082

109,035

101,030

88,161

62,965

75,321

68,060

71,233

65,827

0

0

0

Acquisitions and investments

-

-

-

-

-

55,266

52,554

100,034

111,664

62,370

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of Ellipse Technologies, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

380,080

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other acquisitions and investments

-

-

-

-

-

-

-

-

-

-

-

-

-

108,591

108,150

8,079

8,079

1,357

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of intangible assets

3,164

7,501

7,501

6,827

11,852

7,682

7,682

8,257

3,678

2,270

2,270

1,695

6,140

5,918

9,349

9,349

5,658

32,020

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

5,000

0

0

0

-

-

-

-

Cash paid for business and asset acquisitions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

117,070

122,883

117,946

113,918

106,741

101,921

91,596

94,919

104,785

110,221

111,520

104,496

104,638

88,372

89,749

80,362

63,357

75,772

72,637

73,840

75,728

58,424

55,271

53,948

51,787

47,597

43,501

43,468

35,822

41,189

49,641

49,356

57,937

53,370

48,659

51,731

47,444

45,846

0

0

0

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

128,956

236,724

427,352

392,912

427,945

359,485

217,627

242,161

217,158

231,966

210,546

215,664

218,454

207,498

261,992

284,835

235,919

201,760

309,808

227,192

253,210

297,579

162,717

183,908

203,415

0

0

0

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

407,032

545,837

586,644

559,112

411,471

305,431

235,313

244,353

174,816

174,594

174,935

183,935

216,299

237,225

247,091

230,294

246,504

220,796

182,834

165,612

151,966

186,331

229,970

221,608

204,439

0

0

0

Purchases of restricted investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62,625

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-124,334

-134,484

-128,674

-124,446

-118,481

-161,285

-151,832

-203,210

-220,127

-174,861

-176,602

-153,408

-152,459

-304,885

-278,215

-171,653

-140,843

-7,514

-42,528

-118,916

-138,957

-104,825

-119,501

-96,717

-93,303

-64,570

-15,914

-62,335

-209,017

-147,894

-190,249

-334,782

-162,294

-201,724

-170,856

4,848

-18,717

-45,795

0

0

0

Financing activities:
Purchases of treasury stock

85,119

14,478

13,454

12,408

8,950

2,928

2,968

3,238

3,659

11,860

12,002

13,029

22,491

24,734

28,838

35,541

38,584

56,929

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payment of 2013 Senior Convertible Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

74,311

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Incremental tax benefits related to stock-based compensation awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,185

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

186

0

0

0

Proceeds from the issuance of common stock

-

-

-

-

-

8,127

10,037

9,934

9,917

9,991

8,341

8,711

9,458

9,492

9,734

9,896

11,147

12,106

17,053

17,521

16,008

23,354

20,271

19,492

17,135

8,422

5,193

4,913

4,606

4,884

5,574

5,612

6,741

6,852

6,524

7,202

8,628

14,831

0

0

0

Payment of contingent consideration

-280

809

1,559

11,359

11,985

19,450

0

0

0

-

-

-

-

-

-

-

-

514

514

514

514

498

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible debt, net of issuance costs

0

-

-

-

-

-

-

-

-

-

-

-

-

634,140

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of warrants

0

-

-

-

-

-

-

-

-

-

-

-

-

44,850

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of convertible note hedge

-

-

-

-

-

-

-

-

-

-

-

-

-

111,150

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of convertible note hedge

0

-

-

-

-

-

-

-

-

-

-

-

-

439,519

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from revolving line of credit

-

-

-

-

-

100,000

0

0

0

-

-

-

-

50,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments on revolving line of credit

-

-

-

-

-

100,000

0

0

0

-

-

-

-

50,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other financing activities

-561

2,228

2,192

1,588

1,370

-327

-362

-383

-2,402

-2,442

-2,449

-2,494

-573

-1,834

-1,762

-1,650

-1,589

-192

-156

-136

-142

-693

-758

-832

-858

-162

-925

-937

-697

-721

-237

81

67

-718

-562

-9,861

-4,236

-7,935

0

0

0

Net cash provided by (used in) financing activities

327,471

-6,644

-11,369

-52,476

-66,774

-14,578

-47,593

-49,504

-32,761

-87,028

-144,333

-101,718

-109,712

110,823

203,139

201,967

202,072

-30,344

-12,186

-8,980

614

30,277

26,673

30,426

29,348

-52,482

-91,515

-95,793

-97,121

-22,556

-31,989

-149,911

210,553

209,879

246,101

364,357

3,696

7,082

0

0

0

Effect of exchange rate changes on cash

-1,493

131

-948

-175

-2,377

-1,283

-1,246

-216

2,294

2,070

156

-228

-857

-929

827

374

286

-917

-1,687

-2,348

-2,211

-1,438

-921

506

-373

-861

-415

-855

-18

175

-9

-265

-341

-225

-213

306

225

70

0

0

0

Increase (decrease) in cash, cash equivalents and restricted cash

417,684

94,293

88,288

58,299

19,651

42,037

7,958

-65,807

-65,420

-82,850

-139,885

-130,418

-134,165

-36,906

62,490

184,445

181,611

49,952

10,671

-27,824

-22,283

39,562

30,041

47,581

32,305

-20,474

-7,115

-62,276

-191,708

-40,193

-113,212

-383,928

136,079

70,895

150,353

437,571

56,437

27,184

0

0

0

Supplemental disclosure of non-cash transactions:
Issuance of common stock in connection with royalty milestone achievement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,560

0

0

0

-

-

-

-

-

-

-

-